U.S. FDA moves to strengthen warnings on weight-loss drugs Ozempic and Wegovy over possible vision loss
The U.S. Food and Drug Administration (FDA) is moving to strengthen safety warnings for popular diabetes ...
Read moreDetails
Tag: Ozempic
India set for cheaper Ozempic as key patent expires in March 2026
India’s pharmaceutical landscape is on the brink of a significant shift as the patent on semaglutide, ...
Read moreDetails
